NO20050603L - Vaksine for behandling av respiratoriske infeksjoner og infeksjoner i formeringssystemet til dyr - Google Patents

Vaksine for behandling av respiratoriske infeksjoner og infeksjoner i formeringssystemet til dyr

Info

Publication number: NO20050603L
Authority: NO; Norway
Prior art keywords: leptospira; infections; vaccine; treatment; bovine
Prior art date: 2002-08-26

Application number

NO20050603A

Other languages

English (en)

Norwegian (no)

Inventor

Paul Joseph Dominowski

Mark D Goodyear

Michael J Huether

Original Assignee

Zoetis P Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-26

Filing date

2005-02-03

Publication date

2005-03-17

2005-02-03 Application filed by Zoetis P Llc filed Critical Zoetis P Llc

2005-03-17 Publication of NO20050603L publication Critical patent/NO20050603L/no

Links

241001465754 Metazoa Species 0.000 title abstract 2
208000015181 infectious disease Diseases 0.000 title abstract 2
206010057190 Respiratory tract infections Diseases 0.000 title 1
210000004994 reproductive system Anatomy 0.000 title 1
229960005486 vaccine Drugs 0.000 title 1
241000589902 Leptospira Species 0.000 abstract 3
241000701083 Bovine alphaherpesvirus 1 Species 0.000 abstract 2
241000711895 Bovine orthopneumovirus Species 0.000 abstract 2
241000710780 Bovine viral diarrhea virus 1 Species 0.000 abstract 2
229940001442 combination vaccine Drugs 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
241000589874 Campylobacter fetus Species 0.000 abstract 1
241001550390 Leptospira interrogans serovar Canicola Species 0.000 abstract 1
241001518166 Leptospira interrogans serovar Hardjo-prajitno Species 0.000 abstract 1
241001518154 Leptospira kirschneri serovar Grippotyphosa Species 0.000 abstract 1
208000002606 Paramyxoviridae Infections Diseases 0.000 abstract 1
241000700605 Viruses Species 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/265—Infectious rhinotracheitis virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/28011—Hepeviridae
- C12N2770/28022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biotechnology (AREA)
Reproductive Health (AREA)
Pulmonology (AREA)
Endocrinology (AREA)
Pregnancy & Childbirth (AREA)
Toxicology (AREA)
Gynecology & Obstetrics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO20050603A 2002-08-26 2005-02-03 Vaksine for behandling av respiratoriske infeksjoner og infeksjoner i formeringssystemet til dyr NO20050603L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US40596902P	2002-08-26	2002-08-26
PCT/IB2003/003633 WO2004017990A1 (fr)	2002-08-26	2003-08-14	Vaccin contre les infections de l'appareil genital et du systeme respiratoire chez les bovins

Publications (1)

Publication Number	Publication Date
NO20050603L true NO20050603L (no)	2005-03-17

Family

ID=31946951

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20050603A NO20050603L (no)	2002-08-26	2005-02-03	Vaksine for behandling av respiratoriske infeksjoner og infeksjoner i formeringssystemet til dyr

Country Status (31)

Country	Link
US (4)	US20040081666A1 (fr)
EP (2)	EP1536830A1 (fr)
JP (4)	JP2006501237A (fr)
KR (2)	KR20060116037A (fr)
CN (1)	CN1315534C (fr)
AP (1)	AP2005003238A0 (fr)
AR (1)	AR041047A1 (fr)
AT (1)	ATE533506T1 (fr)
AU (2)	AU2003263390B2 (fr)
BR (1)	BR0313806A (fr)
CA (1)	CA2496750C (fr)
EA (1)	EA011578B1 (fr)
GT (1)	GT200300180A (fr)
HR (2)	HRP20050192B1 (fr)
IS (1)	IS7672A (fr)
MA (1)	MA27388A1 (fr)
ME (1)	ME00810B (fr)
MX (1)	MXPA05002255A (fr)
NO (1)	NO20050603L (fr)
NZ (2)	NZ538394A (fr)
OA (1)	OA12915A (fr)
PA (1)	PA8581101A1 (fr)
PE (1)	PE20040420A1 (fr)
PL (1)	PL216541B1 (fr)
RS (1)	RS20050177A (fr)
TN (1)	TNSN05059A1 (fr)
TW (1)	TWI272105B (fr)
UA (1)	UA94689C2 (fr)
UY (1)	UY27948A1 (fr)
WO (1)	WO2004017990A1 (fr)
ZA (1)	ZA200501171B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7179473B2 (en)	1998-06-05	2007-02-20	Boehringer Ingelheim Vetmedica Gmbh	Attenuated pestiviruses
US7135561B2 (en)	2001-09-06	2006-11-14	Boehringer Ingelheim Vetmedica Gmbh	Infectious bovine viral diarrhea virus clone
RS20050177A (sr) *	2002-08-26	2007-06-04	Pfizer Products Inc.,	Vakcina za infekcije respiratornog i reproduktivnog sistema kod stoke
US20050089533A1 (en) *	2003-01-29	2005-04-28	Joseph Frantz	Canine vaccines against Bordetella bronchiseptica
US7563449B2 (en) *	2003-04-21	2009-07-21	Pfizer Inc,	Methods for reducing cattle reproductive diseases
US7361357B2 (en)	2003-07-29	2008-04-22	Pfizer Inc.	Safe mutant viral vaccines
EP1701738B1 (fr)	2003-12-17	2015-03-11	Wyeth LLC	Méthode pour la production de compositions de VRS stables au stockage
KR20110132416A (ko) *	2004-04-05	2011-12-07	화이자 프로덕츠 인코포레이티드	미세유체화된 수중유 유화액 및 백신 조성물
US7572455B2 (en) *	2004-05-19	2009-08-11	Boehringer Ingelheim Vetmedica Gmbh	Vaccine comprising an attenuated pestivirus
US20090068223A1 (en) *	2005-11-15	2009-03-12	Boehringer Ingelheim Vetmedica, Inc.	Combination vaccine comprising an attenuated bovine viral diarrhea virus
EP2066340B1 (fr)	2006-09-11	2013-07-31	Zoetis P LLC	Bacterines thermotraitees et vaccins en emulsion prepares a partir de telles bacterines thermotraitees
WO2008036747A2 (fr) *	2006-09-21	2008-03-27	Amarillo Biosciences, Inc.	Composition et procédé d'immunomodulation
US7803527B2 (en) *	2007-10-31	2010-09-28	Novartis Ag	Inactivated bovine herpes virus-1 and methods
KR101254848B1 (ko) *	2007-12-21	2013-04-15	화이자 인코포레이티드	열 처리된 박테린, 및 상기 열 처리된 박테린으로부터 제조된 에멀젼 백신
UY31930A (es) *	2008-06-25	2010-01-29	Boheringer Ingelheim Pharma Kg	Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
CN102238961A (zh)	2008-10-03	2011-11-09	诺华公司	牛疱疹病毒1型组合物,疫苗及方法
US8846054B2 (en) *	2009-01-09	2014-09-30	Boehringer Ingelheim Vetmedica, Inc.	Method of treating pregnant cows and/or heifers
RU2395297C1 (ru) *	2009-03-31	2010-07-27	Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ")	Вакцина инактивированная комбинированная против инфекционного ринотрахеита, вирусной диареи и лептоспироза крупного рогатого скота
RU2395299C1 (ru) *	2009-03-31	2010-07-27	Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ")	Вакцина инактивированная комбинированная против инфекционного ринотрахеита, вирусной диареи, рота-, коронавирусной болезней и лептоспироза крупного рогатого скота
PE20140576A1 (es) *	2011-06-10	2014-05-24	Novartis Ag	Vacunas bovinas y metodos
RU2522780C2 (ru) *	2012-07-27	2014-07-20	Государственное научное учреждение Всероссийский научно-исследовательский институт ветеринарной санитарии, гигиены и экологии Российской академии сельскохозяйственных наук	Способ получения вакцины против инфекционного ринотрахеита крупного рогатого скота
US9314519B2 (en)	2012-08-21	2016-04-19	Intervet Inc.	Liquid stable virus vaccines
US20140147475A1 (en)	2012-11-29	2014-05-29	Antonius Arnoldus Christiaan Jacobs	Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
US9393298B2 (en)	2013-03-15	2016-07-19	Intervet Inc.	Liquid stable bovine virus vaccines
US9480739B2 (en) *	2013-03-15	2016-11-01	Intervet Inc.	Bovine virus vaccines that are liquid stable
AU2014234452B2 (en)	2013-03-18	2018-02-22	Intervet International B.V.	Vaccine to protect a ruminant against pneumonia caused by Mannheimia haemolytica
AR097762A1 (es)	2013-09-27	2016-04-13	Intervet Int Bv	Formulaciones secas de vacunas que son estables a temperatura ambiente
AR099470A1 (es)	2014-02-17	2016-07-27	Intervet Int Bv	Vacunas de virus de aves de corral líquidas
TWI670085B (zh)	2014-02-19	2019-09-01	荷蘭商英特威國際公司	液體穩定之豬病毒疫苗
WO2017123201A1 (fr)	2016-01-11	2017-07-20	Zoetis Services Llc	Nouvelles compositions vaccinales à protection croisée pour le virus de la diarrhée épidémique porcine
US11013798B2 (en)	2016-03-21	2021-05-25	South Dakota Board Of Regents	Orf virus-based platform for vaccine delivery
HUE057035T2 (hu)	2016-10-05	2022-04-28	Zoetis Services Llc	Liofilizálási eljárások, amelyek stabilan dhidratált egysejtûeket eredményeznek, potens élõ vakcinaként történõ alkalmazásra
RU2643335C1 (ru) *	2016-11-14	2018-01-31	Федеральное государственное бюджетное образовательное учреждение высшего образования Санкт-Петербургская государственная академия ветеринарной медицины (ФГБОУ ВПО СПбГ АВМ)	Инактивированная бивалентная гидроокись алюминиевая вакцина против кампилобактериоза собак
GB201703529D0 (en)	2017-03-06	2017-04-19	Cambridge Entpr Ltd	Vaccine composition
CN110317749B (zh) *	2019-06-19	2021-01-22	山东省农业科学院奶牛研究中心	一株牛支原体强毒株及其应用
RU2764220C1 (ru) *	2020-12-02	2022-01-14	Федеральное государственное бюджетное научное учреждение "Краснодарский научный центр по зоотехнии и ветеринарии" ФГБНУ КНЦЗВ	Способ предупреждения риска заболевания парагриппом-3 у телят

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3634587A (en) *	1969-11-06	1972-01-11	Ralston Purina Co	Method of immunizing cattle against bovine respiratory disease syndrome
BE759425A (fr) *	1969-11-28	1971-05-25	Mebus Charles A	Vaccins contre la diarrhee du veau, leur preparation et emploi
US5593873A (en)	1986-01-27	1997-01-14	Syntro Corporation	Recombinant infectious bovine rhinotracheitis virus
US5084269A (en)	1986-11-06	1992-01-28	Kullenberg Fred W	Adjuvant for dose treatment with antigens
EP0273512B1 (fr)	1986-12-19	1991-02-27	Duphar International Research B.V	Suspension adjuvante stabilisée comprenant du bromure de diméthyl dioctadécyl ammonium
US6291228B1 (en) *	1988-08-03	2001-09-18	Vericore Limited	Vaccine
GB8818415D0 (en) *	1988-08-03	1988-09-07	Animal Health Inst	Vaccine
MX9301736A (es)	1992-03-30	1994-01-31	Smithkline Beecham Corp	Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1.
US5951988A (en) *	1993-03-30	1999-09-14	University Of Saskatchewan	Adjuvant formulation with enhanced immunogenic activity, and related compositions and methods
NZ276234A (en)	1993-11-05	1998-01-26	Bayer Ag Substituted Under Sec	An attenuated replicating non pathogenic flavivirus (bovine viral diarrhoea virus - bvdv) vaccine
PT759780E (pt) *	1994-05-10	2001-01-31	American Home Prod	Vacina melhorada de vsrb vivo modificado
US5709865A (en)	1994-11-10	1998-01-20	Biostar Inc.	Immunogenic composition against Bovine Viral Diarrhea Virus II glycoprotein 53 (BVDV-II gp53)
US6001613A (en)	1996-05-24	1999-12-14	Board Of Regents Of University Of Nebraska	Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid
US6060457A (en)	1996-06-20	2000-05-09	Universite De Montreal	DNA plasmid vaccine for immunization of animals against BVDV
BR9803232A (pt) *	1997-08-26	2000-01-11	Pfizer Prod Inc	Vaicna de neospora.
AU1145699A (en) *	1997-09-05	1999-03-22	Smithkline Beecham Biologicals (Sa)	Oil in water emulsions containing saponins
UA78180C2 (uk) *	1997-10-03	2007-03-15	Меріаль	Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
EP0924295A3 (fr) *	1997-12-04	2001-05-16	Pfizer Products Inc.	Gène de dihydrofolate reductase-thymidilate synthase de neospora
WO1999055366A1 (fr)	1998-04-24	1999-11-04	Washington University	Chimeres du virus de l'hepatite c et virus de la diarrhee virale des bovins
AU769539B2 (en) *	1999-01-29	2004-01-29	Zoetis Services Llc	Adjuvants for use in vaccines
RS20050177A (sr) *	2002-08-26	2007-06-04	Pfizer Products Inc.,	Vakcina za infekcije respiratornog i reproduktivnog sistema kod stoke
BRPI0808259A2 (pt)	2007-03-05	2014-07-08	Cadila Healthcare Ltd. ,	"formulação, processo de liofilização, formulação liofilizada, e processo para preparar uma formulação liofilizada"

2003
- 2003-08-14 RS YUP-2005/0177A patent/RS20050177A/sr unknown
- 2003-08-14 AT AT06122758T patent/ATE533506T1/de active
- 2003-08-14 BR BR0313806-2A patent/BR0313806A/pt not_active Application Discontinuation
- 2003-08-14 EP EP03792580A patent/EP1536830A1/fr not_active Ceased
- 2003-08-14 UA UAA200501771A patent/UA94689C2/ru unknown
- 2003-08-14 KR KR1020067022893A patent/KR20060116037A/ko not_active Ceased
- 2003-08-14 EP EP06122758A patent/EP1743652B1/fr not_active Expired - Lifetime
- 2003-08-14 AP AP2005003238A patent/AP2005003238A0/xx unknown
- 2003-08-14 EA EA200500275A patent/EA011578B1/ru not_active IP Right Cessation
- 2003-08-14 CN CNB038203162A patent/CN1315534C/zh not_active Expired - Lifetime
- 2003-08-14 KR KR1020057003230A patent/KR20050062542A/ko not_active Ceased
- 2003-08-14 HR HRP20050192AA patent/HRP20050192B1/hr not_active IP Right Cessation
- 2003-08-14 AU AU2003263390A patent/AU2003263390B2/en not_active Expired
- 2003-08-14 ME MEP-2009-213A patent/ME00810B/fr unknown
- 2003-08-14 CA CA2496750A patent/CA2496750C/fr not_active Expired - Lifetime
- 2003-08-14 MX MXPA05002255A patent/MXPA05002255A/es active IP Right Grant
- 2003-08-14 NZ NZ538394A patent/NZ538394A/en not_active IP Right Cessation
- 2003-08-14 PL PL375548A patent/PL216541B1/pl unknown
- 2003-08-14 JP JP2004530459A patent/JP2006501237A/ja active Pending
- 2003-08-14 NZ NZ565206A patent/NZ565206A/en not_active IP Right Cessation
- 2003-08-14 HR HR20090271A patent/HRP20090271A2/xx not_active Application Discontinuation
- 2003-08-14 OA OA1200500058A patent/OA12915A/en unknown
- 2003-08-14 WO PCT/IB2003/003633 patent/WO2004017990A1/fr not_active Ceased
- 2003-08-20 TW TW092122872A patent/TWI272105B/zh not_active IP Right Cessation
- 2003-08-22 PE PE2003000857A patent/PE20040420A1/es not_active Application Discontinuation
- 2003-08-22 UY UY27948A patent/UY27948A1/es not_active Application Discontinuation
- 2003-08-25 GT GT200300180A patent/GT200300180A/es unknown
- 2003-08-25 PA PA20038581101A patent/PA8581101A1/es unknown
- 2003-08-25 AR ARP030103054A patent/AR041047A1/es unknown
- 2003-08-26 US US10/647,919 patent/US20040081666A1/en not_active Abandoned
2005
- 2005-01-27 IS IS7672A patent/IS7672A/is unknown
- 2005-02-03 NO NO20050603A patent/NO20050603L/no not_active Application Discontinuation
- 2005-02-09 ZA ZA200501171A patent/ZA200501171B/en unknown
- 2005-02-25 MA MA28121A patent/MA27388A1/fr unknown
- 2005-02-25 TN TNP2005000059A patent/TNSN05059A1/fr unknown
2007
- 2007-08-30 US US11/897,421 patent/US20070298053A1/en not_active Abandoned
2008
- 2008-12-16 AU AU2008258154A patent/AU2008258154B2/en not_active Expired
2009
- 2009-05-15 JP JP2009118662A patent/JP2009215309A/ja not_active Withdrawn
2010
- 2010-06-22 US US12/820,566 patent/US9662384B2/en active Active
2011
- 2011-12-16 JP JP2011275303A patent/JP5785073B2/ja not_active Expired - Lifetime
2012
- 2012-12-28 US US13/729,206 patent/US20130129779A1/en not_active Abandoned
2015
- 2015-06-03 JP JP2015113008A patent/JP2015172069A/ja active Pending

Also Published As

Publication number	Publication date
PL216541B1 (pl)	2014-04-30
WO2004017990A1 (fr)	2004-03-04
AP2005003238A0 (en)	2005-03-31
CA2496750C (fr)	2014-10-21
RS20050177A (sr)	2007-06-04
JP5785073B2 (ja)	2015-09-24
EA200500275A1 (ru)	2005-08-25
TNSN05059A1 (fr)	2007-05-14
AU2003263390B2 (en)	2008-12-18
US20130129779A1 (en)	2013-05-23
NZ538394A (en)	2008-06-30
CA2496750A1 (fr)	2004-03-04
JP2012092126A (ja)	2012-05-17
US20040081666A1 (en)	2004-04-29
ZA200501171B (en)	2006-12-27
MA27388A1 (fr)	2005-06-01
KR20050062542A (ko)	2005-06-23
ME00810B (fr)	2012-03-20
NZ565206A (en)	2008-12-24
JP2006501237A (ja)	2006-01-12
US9662384B2 (en)	2017-05-30
UY27948A1 (es)	2004-03-31
KR20060116037A (ko)	2006-11-13
GT200300180A (es)	2004-05-18
UA94689C2 (ru)	2011-06-10
HRP20050192B1 (hr)	2014-02-14
HK1078457A1 (en)	2006-03-17
EP1743652B1 (fr)	2011-11-16
AU2008258154A1 (en)	2009-01-08
US20100266629A1 (en)	2010-10-21
AU2008258154B2 (en)	2011-07-21
TW200404565A (en)	2004-04-01
PE20040420A1 (es)	2004-07-24
JP2015172069A (ja)	2015-10-01
EP1743652A1 (fr)	2007-01-17
US20070298053A1 (en)	2007-12-27
JP2009215309A (ja)	2009-09-24
MXPA05002255A (es)	2005-06-08
EA011578B1 (ru)	2009-04-28
HRP20090271A2 (en)	2009-11-30
AU2003263390A1 (en)	2004-03-11
TWI272105B (en)	2007-02-01
CN1678346A (zh)	2005-10-05
PA8581101A1 (es)	2005-11-25
HRP20050192A2 (en)	2005-06-30
AR041047A1 (es)	2005-04-27
BR0313806A (pt)	2005-07-05
CN1315534C (zh)	2007-05-16
PL375548A1 (en)	2005-11-28
EP1536830A1 (fr)	2005-06-08
OA12915A (en)	2006-10-13
ATE533506T1 (de)	2011-12-15
IS7672A (is)	2005-01-27

Legal Events

Date	Code	Title	Description
2013-05-21	CHAD	Change of the owner's name or address (par. 44 patent law, par. patentforskriften)	Owner name: ZOETIS P LLC, US
2016-04-18	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20050603L (no)	2005-03-17	Vaksine for behandling av respiratoriske infeksjoner og infeksjoner i formeringssystemet til dyr
WO2004093904A3 (fr)	2004-12-23	Methodes pour prevenir les maladies genesiques des bovins
HUP9902791A2 (hu)	1999-12-28	Polinukleotid-vakcinakészítmény, elsősorban szarvasmarhák légzőszervi kórképei ellen
PL330879A1 (en)	1999-06-07	Recombine live vaccine based on canine herpes virus, in particular against carre disease, rabies or parainfluenza virus of type 2
AU7814498A (en)	1998-12-30	Multivalent (in ovo) avian vaccine
AP2005003237A0 (en)	2005-03-31	Vaccine for respiratory and reproductive system infections in cattle.
UA40571C2 (uk)	2001-08-15	Мутант коров'ячого вірусу герпесу типу 1 (bhv-1), композиція вакцини для вакцинації тварин для захисту їх від bhv-1, композиція вакцини для вакцинації тварин для захисту їх від патогена
PT933993E (pt)	2006-10-31	Compostos de ciclopentano substituidos, uteis como inibidores de neuraminidase
MXPA03011815A (es)	2004-04-02	Vacuna de micoplasma bovis y metodos para reducir la neumonia en animales.
BR9911094A (pt)	2001-10-30	Composições e métodos para o tratamento detosse
ATE375804T1 (de)	2007-11-15	Ribavirin-enthaltende vakzine
WO2004085682A3 (fr)	2005-03-31	Utilisation de substances actives pour la prevention ou le traitement de maladies virales, et systeme de test pour la recherche de telles substances actives
CO5280138A1 (es)	2003-05-30	Virus atenuados e inocuos de la diarrea virica bovina para en vacas gestantes
BR0012433A (pt)	2002-05-21	Vìrus recombinante, infeccioso de doença bursal infecciosa, método para obter o mesmo, ibdv mosaico infeccioso (mibdv), e, vacina
WO2004043404A3 (fr)	2004-09-23	Procede de conception d'inhibiteurs de la proteine 1 non-structurale de virus grippaux
WO2004014316A3 (fr)	2004-06-17	Composes, compositions et techniques de traitement et de prevention de l'infection par des pneumovirus et de maladies associees
WO1999049017A3 (fr)	1999-12-16	Mutations responsables de l'attenuation du virus de la rougeole ou du virus respiratoire syncytial humain du sous-groupe b
DOP2003000699A (es)	2004-02-29	Vacunas para enfermedades reproductoras del ganado
McCaw	1995	Caring for the retrovirus infected cat
JPS56115724A (en)	1981-09-11	Prophilaxis and remedy for avian infectious coryza
Kaufman et al.	2016	0762 Feeding low crude protein diets in lactating dairy cows during summer months: 1. Improvements in milk production and nitrogen utilization
CO5690616A2 (es)	2006-10-31	Vacunas para enfermedades reproductoras del ganado
AR084225A1 (es)	2013-05-02	Composiciones y metodos para vacunar ganado vacuno
Makoschey et al.	2009	Combined application of an inactivated IBR marker vaccine and an inactivated BVD vaccine.